Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Common Equity (2019 - 2025)

Volitionrx's Common Equity history spans 9 years, with the latest figure at -$34.2 million for Q4 2025.

  • For Q4 2025, Common Equity fell 37.49% year-over-year to -$34.2 million; the TTM value through Dec 2025 reached -$34.2 million, down 37.49%, while the annual FY2025 figure was -$34.2 million, 37.49% down from the prior year.
  • Common Equity reached -$34.2 million in Q4 2025 per VNRX's latest filing, up from -$34.6 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $31.2 million in Q1 2021 to a low of -$34.6 million in Q3 2025.
  • Average Common Equity over 5 years is -$5.8 million, with a median of -$3.1 million recorded in 2022.
  • Peak YoY movement for Common Equity: surged 239.27% in 2021, then crashed 694.03% in 2024.
  • A 5-year view of Common Equity shows it stood at $17.7 million in 2021, then crashed by 117.64% to -$3.1 million in 2022, then crashed by 178.62% to -$8.7 million in 2023, then tumbled by 185.89% to -$24.9 million in 2024, then tumbled by 37.49% to -$34.2 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Common Equity are -$34.2 million (Q4 2025), -$34.6 million (Q3 2025), and -$33.1 million (Q2 2025).